Skip to main content

Peer Review reports

From: Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients

Original Submission
18 Feb 2021 Submitted Original manuscript
18 Mar 2021 Reviewed Reviewer Report
19 Apr 2021 Reviewed Reviewer Report - Kamwing Jair
3 May 2021 Author responded Author comments - Naveed Ullah Khan
Resubmission - Version 2
3 May 2021 Submitted Manuscript version 2
5 May 2021 Author responded Author comments - Naveed Ullah Khan
Resubmission - Version 3
5 May 2021 Submitted Manuscript version 3
8 May 2021 Author responded Author comments - Naveed Ullah Khan
Resubmission - Version 4
8 May 2021 Submitted Manuscript version 4
18 May 2021 Author responded Author comments - Naveed Ullah Khan
Resubmission - Version 5
18 May 2021 Submitted Manuscript version 5
19 May 2021 Author responded Author comments - Naveed Ullah Khan
Resubmission - Version 6
19 May 2021 Submitted Manuscript version 6
Publishing
1 Jun 2021 Editorially accepted
12 Jun 2021 Article published 10.1186/s12920-021-01004-y

You can find further information about peer review here.

Back to article page